有研究提示尿液肌氨酸水平似乎可以成为诊断恶性侵袭性前列腺癌的新型分子标志物,其比血清前列腺特异性抗原更具特异性和灵敏性,但这一结论尚存在争议。全文结合了两种不同的研究文献,对肌氨酸及其在前列腺癌诊治中的作用作一综述。 Some studies suggest that urine sarcosine level seems to be a new molecular marker for the diagnosis of malignant and aggressive prostate cancer, which is more specific and sensitive than serum prostate specific antigen. However, this conclusion is still controversial. This article combines two different types of research literature and reviews the role of sarcosine in the diagnosis and treatment of prostate cancer.